Homayoun Sameh-Yah, a member of the Health Commission of the Parliament, warned that the pharmaceutical industry is on the brink of bankruptcy due to currency and financial problems. He stated that if preventive measures are not taken, the country will face deeper and more costly crises in the health sector in the near future, and we should expect an increase in drug prices.
Member of the Health Commission: We Should Expect an Increase in Drug Prices
Homayoun Sameh-Yah, a member of Iran's Health Commission, has warned of an impending crisis in the pharmaceutical industry due to financial issues. He emphasizes the need for preventive measures to avoid a significant increase in drug prices and deeper health crises.
👥 Key Players
📰 What Happened
Homayoun Sameh-Yah has issued a warning about the looming bankruptcy of Iran's pharmaceutical industry due to financial difficulties. He cautioned that without intervention, drug prices will rise and the health sector will face severe crises.
- The pharmaceutical industry is experiencing financial strain due to currency issues.
- Preventive measures are deemed necessary to avert a health crisis.
💡 Why It Matters
📚 Background
Iran has been grappling with economic challenges, including high inflation and currency devaluation, which have impacted various sectors, including healthcare.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%